Skip Navigation



Journal of Intellectual Property Law & Practice Advance Access published online on May 20, 2009
Journal of Intellectual Property Law & Practice, doi:10.1093/jiplp/jpp075
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
4/7/459    most recent
jpp075v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Inman, P.
Right arrow Articles by Spink, S.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Authors (2009). Published by Oxford University Press. All rights reserved.

Current Intelligence

House of Lords addresses ‘Biogen insufficiency’

Paul Inman and Simon Spink
Howrey LLP
Email: spinks{at}howrey.com

Generics (UK) Limited & Ors v H. Lundbeck A/S [2009] UKHL 12, 25 February 2009

Simple patent product claims are not caught by the principles of Biogen insufficiency, but the precise scope of those principles is left unclear.

Correspondence: Email: inmanp{at}howrey.com


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.